Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-09-24

Clinical Trial Update: Helicobacter in The Gambia (Part 2)

View source ↗

Summary

Clinical trial NCT00467155 in The Gambia investigating Helicobacter pylori has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical Research Council Unit, The Gambia | Conditions: Helicobacter Pylori | Status: WITHDRAWN